medline.ch Onkologie Blut

	Impact on Fertility Outcomes in Survivors after Oncological Treatment of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis. J Adolesc Young Adult Oncol Wunder D, Stefanou E, Vidal A, Pape J, Karrer T, Novak U, von Wolff M. PMID: 42287018 [PubMed - as supplied by publisher]
	Emerging treatment strategies for newly diagnosed diffuse large B-cell lymphoma. Int J Clin Oncol Miyazaki K. PMID: 42286378 [PubMed - as supplied by publisher]
	Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial. Lancet Haematol Vitolo U, Burgues JMB, Duell J, Kwiatek M, Belada D, Jurczak W, Maerevoet M, Sibon D, Greil R, Kumode T, López-Jimenez J, Meert C, Cia JS, Thieblemont C, Alcaide SO, Kim WS, Cordoba R, Wielgos-Bonvallet M, Jiang T, Wang Y, McGoldrick S, Guo E, Morschhauser F, Woei-A-Jin FJSH. PMID: 42285113 [PubMed - as supplied by publisher]
	Brentuximab vedotin in cutaneous T-Cell lymphoma: emerging evidence and therapeutic insights for CD30-negative and CD30-low disease. Cancer Treat Res Commun Morecroft R, Phillipps J, Moustafa MA. PMID: 42284847 [PubMed - as supplied by publisher]
	FLAG-Based Versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis. Oncology Abdulgayoom M, Aboukhalaf S, Osman M, H Soliman N, Rahmoon SM, Rabadi M, Fituri N, Al-Mashdali AF, Kaddoura R, F Mohamed S. PMID: 42284251 [PubMed - as supplied by publisher]
	Overcoming chemotherapy resistance in diffuse large B-cell lymphoma using multifunctional nanocarriers: current advances and clinical challenges. Discov Nano Li D, Ke X, Hu K. PMID: 42283995 [PubMed]
	Impact of oral mucositis treated by photobiomodulation protocol on the quality of life of pediatric oncology patients with acute lymphoblastic leukemia. Lasers Med Sci Alves de Melo Júnior W, Correia Basto da Silva G, Suely Barros Dantas F, Cássia Gomes Aciole R, Luiz Affonso Fonseca F, Aparecida da Silva Pinhal M. PMID: 42283739 [PubMed - indexed for MEDLINE]
	A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma. Am J Hematol Chavez JC, Bastos-Oreiro M, Diefenbach C, Lossos IS, Shah N, Assouline S, Olszewski AJ, Naik S, Ghosh N, Pham S, Wei MC, Batlevi C, To I, Ead W, Makadia S, Penuel E, Jing J, Budde LE. PMID: 42283231 [PubMed - as supplied by publisher]
	TRBC1/CD3 dual color immunohistochemistry: An effective test to support a diagnosis of T-cell lymphoma in cytology specimens. Cancer Cytopathol Wu SJ, Mito JK. PMID: 42283121 [PubMed - in process]
	Application of NanoString Technologies in Chronic Myeloid Leukemia, Essential Thrombocythemia, Primary Myelofibrosis, and Polycythemia Vera: A Pilot Study. Diagnostics (Basel) Bae JH, Bae KJ, Cho CH. PMID: 42279591 [PubMed]
	Classic Hodgkin Lymphoma Beyond the Lymph Node: A Systemic Immunobiological Paradigm. Cancers (Basel) Carbone A, Gloghini A. PMID: 42279396 [PubMed]
	A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial. Cancers (Basel) Pirosa MC, Hess D, Krasniqi F, Novak U, Mach N, Zenz T, Holer L, Cascione L, Cannas E, Rinaldi A, Schär S, Zucca E, Bertoni F, Stathis A, Swiss Group for Clinical Cancer Research SAKK. PMID: 42279347 [PubMed]
	Radiogenomics in Lymphoma and Multiple Myeloma: A Systematic Review of Current Evidence and Future Directions. J Clin Med Formica V, Aghakhanyan G, Baccolini V, Caputo FP, Fanni SC, Francischello R, Migliara G, Volterrani D, Lencioni RA, Villari P, Neri E, Cioni D. PMID: 42278909 [PubMed]
	Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack(Â®) Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL Study. Int J Mol Sci Della Starza I, Bellomarino V, Di Trani M, Cappelli LV, Spinelli O, Cavagna R, Tosi M, Terragna C, Armuzzi S, Robustelli V, Taurisano B, Santoro A, Salemi D, Izzo B, Errichiello S, Galdiero A, Visconti R, Quarantelli F, Potenza A, Caradonna MF, Marzorati M, Fazio G, Cazzaniga G, Cardinali D, Kaiser F, D'Antuono I, Chiaretti S, Guarini A, Foà R. PMID: 42278640 [PubMed - indexed for MEDLINE]
	Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies. Int J Mol Sci Meza K, Barrientos Risso C, Shah A, Romagnoli C, Sandoval J, Brauchle Y, Lyubimova A, Santos L, Goya Balaguer E, Barrientos J. PMID: 42278639 [PubMed - in process]
	The Prognostic Value of Circulating Tumor DNA for Clinical Outcomes in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis. Int J Mol Sci Dac DT, Tanaka H, Takami A, Espinoza JL. PMID: 42278600 [PubMed - indexed for MEDLINE]
	Menin Inhibition in Acute Myeloid Leukemia: Rewiring Leukemic Transcriptional Networks. Int J Mol Sci Tarhini A, Romanos M, Al-Kali A, Saliba AN. PMID: 42278415 [PubMed - in process]
	RUNX1 Alterations in Pediatric Myeloid Malignancies: Divergent Germline and Somatic Trajectories. Int J Mol Sci Bic, Marcu AD, Jercan CG, Radu LE, Avramescu I, Jardan C, Jardan D, C, Mambet C, Coli. PMID: 42278335 [PubMed - indexed for MEDLINE]
	Vitreoretinal Lymphoma: a clinical case highlighting the diagnostic and therapeutic challenge and the need for a multidisciplinary management. Ann Hematol Mayo MS, Martínez AC, Moras LC, Castronuño DA, Álvarez MG, Muñez ÓJB, Sancho AMG, Gutiérrez Gutiérrez NC. PMID: 42277444 [PubMed - as supplied by publisher]
	Target Trial Emulation of Second-Generation Versus First-Generation Tyrosine Kinase Inhibitors in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. JCO Oncol Pract Zhang X, Jhou HJ, Chen HY, Xiao N, Chen PH, Lee CH. PMID: 42275626 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 168254

Seite 1 von 8413

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung